NSHG-PM Webinar: Update from Finland – FinnGen and Finding Functional Variants in a Founder Population

               Mark Daly

17 June 2021. The 2020-2021 NSHG-PM webinar series continued on 16 June 2021 with a presentation titled "Update from Finland – FinnGen and Finding Functional Variants in a Founder Population" by Mark Daly, Jukka Koskela, and Sanni Ruotsalainen, Institute for Molecular Medicine Finland.

In addition to audience Q&A, there was a panel discussion with Ole Andreassen of Oslo University Hospital, Tõnu Esko of University of Tartu, Kristian Hveem of Norwegian University of Science and Technology, and Kári Stefánsson and Hreinn Stefánsson of deCODE genetics.

The webinar included four presentations

  • FinnGen Update and Data Access Solutions, Mark Daly
  • Novel Mechanism Linking IPF and Cancer, Jukka Koskela
  • A Novel Protective Mechanism in Atherosclerosis, Sanni Ruotsalainen
  • Update on Schizophrenia Work In Finland and Worldwide, Mark Daly


Listen to the Webinar

Watch previous webinars.


About the Society

The Nordic Society of Human Genetics and Precision Medicine (NSHG-PM) works with stakeholders at national, regional, and global levels to: 1) establish a Nordic framework for research into the genetics of human diseases, evolution, and population history; 2) accelerate discovery of disease-influencing genes; 3) translate these findings for precision medicine to improve public health; and 4) uphold and promote the highest legal, regulatory, social, and ethical standards.

The benefits of membership for you and your research include reduced registration fees at NSHG-PM conferences, symposia, and select workshops. Equally important, you are helping to support the field as NSHG-PM works to educate and advocate for human genetics and precision medicine research in academic, policy, and public education arenas.

NSHG-PM membership runs from January to December. However, because of the COVID-19 pandemic, complimentary 2021 membership will be included for members who pay or join in 2020.